$IPA
ImmunoPrecise Antibodies Ltd
PRICE
$6.14 ▼-3.762%
Last Close
VOLUME
15,236
DAY RANGE
5.5974 - 6.39
52 WEEK
3.51 - 8.1
Key Metrics
Market Cap
138.84 M
Beta
0.70
Avg. Volume
16.51 K
Shares Outstanding
24.84 M
Yield
0%
Public Float
0
Next Earnings Date
2022-09-08
Next Dividend Date
Company Information
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.
Website: www.immunoprecise.com
HQ: 4464 Markham St Unit 3204 Victoria, V8Z 7X8 British Columbia
Related News